CoChat

Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates

Open access

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Strong genetic data link the Tyrosine kinase receptor B (TrkB) and its major endogenous ligand brain-derived neurotrophic factor (BDNF) to the regulation of energy homeostasis, with loss-of-function mutations in either gene causing severe obesity in both mice and humans. It has previously been reported that peripheral administration of the endogenous TrkB agonist ligand neurotrophin-4 (NT-4) profoundly decreases food intake and body weight in rodents, while paradoxically increasing these same parameters in monkeys. We generated a humanized TrkB agonist antibody, TAM-163, and characterized its therapeutic potential in several models of type 2 diabetes and obesity. In vitro, TAM-163 bound to human and rodent TrkB with high affinity, activated all aspects of the TrkB signaling cascade and induced TrkB internalization and degradation in a manner similar to BDNF. In vivo, peripheral administration of TAM-163 decreased food intake and/or body weight in mice, rats, hamsters, and dogs, but increased food intake and body weight in monkeys. The magnitude of weight change was similar in rodents and non-human primates, occurred at doses where there was no appreciable penetration into deep structures of the brain, and could not be explained by differences in exposures between species. Rather, peripherally administered TAM-163 localized to areas in the hypothalamus and the brain stem located outside the blood-brain barrier in a similar manner between rodents and non-human primates, suggesting differences in neuroanatomy across species. Our data demonstrate that a TrkB agonist antibody, administered peripherally, causes species-dependent effects on body weight similar to the endogenous TrkB ligand NT-4. The possible clinical utility of TrkB agonism in treating weight regulatory disorder, such as obesity or cachexia, will require evaluation in man.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0062616

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 TAM-163 selectively activates recombinant human and mouse TrkB. Phosphorylation of TrkB, PLCγ1, AKT and ERK1/2 in HEK293 cells transfected with human TrkB (A), mouse TrkB (B) or human TrkA, TrkB or TrkC (C). I: hIgG, C: Positive controls (BDNF (Parental and TrkB), NGF (TrkA), NT-3 (TrkC)), T: TAM-163. Recruitment of SHC1 to hTrkB in U2OS cells (D). Luciferase reporter assay in HEK293 cells expressing human TrkB (E).
Figure 1 TAM-163 selectively activates recombinant human and mouse TrkB. Phosphorylation of TrkB, PLCγ1, AKT and ERK1/2 in HEK293 cells transfected with human TrkB (A), mouse TrkB (B) or human TrkA, TrkB or TrkC (C). I: hIgG, C: Positive controls (BDNF (Parental and TrkB), NGF (TrkA), NT-3 (TrkC)), T: TAM-163. Recruitment of SHC1 to hTrkB in U2OS cells (D). Luciferase reporter assay in HEK293 cells expressing human TrkB (E).CC BY · PubMed Central
Figure 2 TAM-163 activates endogenous human TrkB. Phosphorylation of PLCγ1, AKT and ERK1/2 in human neuroblastoma SH-SY5Y (A). Internalization (B) and degradation (C) of hTrkB in SH-SY5Y cells.
Figure 2 TAM-163 activates endogenous human TrkB. Phosphorylation of PLCγ1, AKT and ERK1/2 in human neuroblastoma SH-SY5Y (A). Internalization (B) and degradation (C) of hTrkB in SH-SY5Y cells.CC BY · PubMed Central
Figure 3 TAM-163 induces body weight loss and appetite suppression in several animal species. Body weight, food intake and serum insulin levels in diet-induced obese (DIO) mice (A–C) or Zucker Diabetic Fatty (ZDF) rats (D–F) (n = 8–10 per group). Body weight of Syrian gold hamsters fed a high-fat high-cholesterol diet plus 10% sucrose in drinking water for 2 weeks prior to study initiation (G) (n = 9 per group). Body weight of chow fed adult beagle dogs (H) (n = 4 for vehicle and n = 8 for TAM-163-treated dogs). Vehicle: filled diamonds, TAM-163 0.1 mg/kg: filled circles, TAM-163 1 mg/kg: open squares, TAM-163 3 mg/kg: filled triangles, TAM-163 10 mg/kg: open circles. Data is shown as mean ± SEM, *p<0.05 when comparing TAM-163-treated animals with vehicle-treated animals.
Figure 3 TAM-163 induces body weight loss and appetite suppression in several animal species. Body weight, food intake and serum insulin levels in diet-induced obese (DIO) mice (A–C) or Zucker Diabetic Fatty (ZDF) rats (D–F) (n = 8–10 per group). Body weight of Syrian gold hamsters fed a high-fat high-cholesterol diet plus 10% sucrose in drinking water for 2 weeks prior to study initiation (G) (n = 9 per group). Body weight of chow fed adult beagle dogs (H) (n = 4 for vehicle and n = 8 for TAM-163-treated dogs). Vehicle: filled diamonds, TAM-163 0.1 mg/kg: filled circles, TAM-163 1 mg/kg: open squares, TAM-163 3 mg/kg: filled triangles, TAM-163 10 mg/kg: open circles. Data is shown as mean ± SEM, *p<0.05 when comparing TAM-163-treated animals with vehicle-treated animals.CC BY · PubMed Central
Figure 4 Single dose TAM-163 induces body weight gain and increases food intake in high-fat fed obese rhesus monkeys. Body weight (A) and food intake (B) of male rhesus monkeys fed a high-fat diet for 9 months. Animals received a single dose of vehicle (his-sucrose) or TAM-163 (1, 3 or 10 mg/kg) and were followed for a total of 35 days. Data is shown as mean ± SEM, *p<0.05 as compared to pre-TAM-163 administration. (n = 5 per group). TAM-163 1 mg/kg: open squares, TAM-163 3 mg/kg: filled triangles.
Figure 4 Single dose TAM-163 induces body weight gain and increases food intake in high-fat fed obese rhesus monkeys. Body weight (A) and food intake (B) of male rhesus monkeys fed a high-fat diet for 9 months. Animals received a single dose of vehicle (his-sucrose) or TAM-163 (1, 3 or 10 mg/kg) and were followed for a total of 35 days. Data is shown as mean ± SEM, *p<0.05 as compared to pre-TAM-163 administration. (n = 5 per group). TAM-163 1 mg/kg: open squares, TAM-163 3 mg/kg: filled triangles.CC BY · PubMed Central
Figure 5 Repeated dosing of TAM-163 induces body weight gain and increases food intake in high-fat fed obese rhesus monkeys. Body weight (A), body composition (B) and food intake (C) of male rhesus monkeys fed a high-fat diet for 9 months. Animals received four weekly doses of vehicle (his-sucrose), 4 weekly doses of TAM-163 (10 mg/kg) and were washed-out with 4 weekly doses of vehicle. Body weight and food intake were recorded for a total of 91 days. Body composition was performed after the last dose of vehicle (∼day 25) and TAM-163 (∼day 53). Data is shown as mean ± SEM, *p<0.05 as compared to pre-TAM-163 administration. (n = 10).
Figure 5 Repeated dosing of TAM-163 induces body weight gain and increases food intake in high-fat fed obese rhesus monkeys. Body weight (A), body composition (B) and food intake (C) of male rhesus monkeys fed a high-fat diet for 9 months. Animals received four weekly doses of vehicle (his-sucrose), 4 weekly doses of TAM-163 (10 mg/kg) and were washed-out with 4 weekly doses of vehicle. Body weight and food intake were recorded for a total of 91 days. Body composition was performed after the last dose of vehicle (∼day 25) and TAM-163 (∼day 53). Data is shown as mean ± SEM, *p<0.05 as compared to pre-TAM-163 administration. (n = 10).CC BY · PubMed Central
Figure 6 TAM-163 localizes to the mediobasal hypothalamus and dorsal-vagal complex of the brain in both mice and monkeys. A single dose of Alexa-labeled TAM-163 was injected to mice (10 mg/kg, IP) or monkeys (10 mg/kg, IV) and detected in the hypothalamus and dorsal vagal complex of the brain 6 hrs after administration in diet-induce obese (DIO) mice (A) or lean cynomolgus monkeys (B). (n = 3–4 per group).
Figure 6 TAM-163 localizes to the mediobasal hypothalamus and dorsal-vagal complex of the brain in both mice and monkeys. A single dose of Alexa-labeled TAM-163 was injected to mice (10 mg/kg, IP) or monkeys (10 mg/kg, IV) and detected in the hypothalamus and dorsal vagal complex of the brain 6 hrs after administration in diet-induce obese (DIO) mice (A) or lean cynomolgus monkeys (B). (n = 3–4 per group).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 27

Metadata

Authors
Perreault, M., Feng, G., Will, S., Gareski, T., Kubasiak, D., Marquette, K., Vugmeyster, Y., Unger, T. J., Jones, J., Qadri, A., Hahm, S., Sun, Y., Rohde, C. M., Zwijnenberg, R., Paulsen, J., & Gimeno, R. E.
Affiliations
Pfizer (United States) (US)
Corresponding author
Perreault, Mylène
Venue
PLoS ONE
Published
2013-05-20
Volume
8
Issue
5
Pages
e62616
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2055083670
Cited by
26
References
28
Citations by year
2026: 1 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 3 · 2015: 3 · 2014: 1 · 2013: 1
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
TrkB, neurotrophin-4, brain-derived neurotrophic factor, body weight regulation, dietary intake, species differences, obesity, type 2 diabetes, hypothalamus, brainstem, blood-brain barrier, cachexia, energy homeostasis, neuroanatomy
MeSH terms
Animals, Antibodies, Monoclonal, Appetite Depressants, Body Weight, Energy Intake, Dogs, Drug Evaluation, Preclinical, Female, Cricetinae, Humans, Hypothalamus, Macaca fascicularis, Macaca mulatta, Male, Mesocricetus, Mice, Inbred C57BL, Obesity, Rats, Zucker, Tissue Distribution, Rats, Sprague-Dawley, Receptor, trkB, Mice, Rats, HEK293 Cells, Diet, High-Fat, Administration, Intravenous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates. https://app.cochat.ai/papers/10.1371/journal.pone.0062616
The paper
Perreault, M., Feng, G., Will, S., Gareski, T., Kubasiak, D., Marquette, K., Vugmeyster, Y., Unger, T. J., Jones, J., Qadri, A., Hahm, S., Sun, Y., Rohde, C. M., Zwijnenberg, R., Paulsen, J., & Gimeno, R. E. (2013). Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates. PLoS ONE. https://doi.org/10.1371/journal.pone.0062616

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.